Nashwa Amin | Medicine and Health Sciences | Best Researcher Award

Dr. Nashwa Amin | Medicine and Health Sciences | Best Researcher Award

Postdoctoral Fellow | Aswan University | Egypt

Dr. Nashwa Amin candidate is an experienced academic with over fourteen years of teaching and research in zoology, cell biology, and neuroscience, with appointments at Aswan University, Egypt, and Zhejiang University, China. Their educational background includes a PhD in cell biology from Zhejiang University, an MSc in zoology, and a BSc with honors in science from Aswan University. Professionally, they have served as a lecturer, assistant lecturer, postdoctoral research associate, and research fellow, contributing to both teaching and advanced research in neuroscience and neurodegenerative diseases. Their research interests focus on developing new therapeutic strategies for ischemic stroke, depression, and other neurological disorders, with emphasis on neuroprotective mechanisms and translational medicine. They have actively contributed to national and international research projects funded by the National Natural Science Foundation of China and have published widely in high-impact, peer-reviewed journals indexed in Scopus and Web of Science. Recognized with scientific publishing awards from Aswan University, the candidate has also demonstrated strong research skills in both in vivo and in vitro experimental models, molecular and cellular techniques, and advanced neurobehavioral analysis. With a solid track record of academic service, mentorship, and community involvement, they continue to make meaningful contributions to science and higher education. The research profile further reflects measurable impact, with 310 citations by 299 documents, 21 publications, and an h-index of 12.

Profiles: ORCID | Scopus

Featured Publications

1.  Amin, N., Wu, F., Zhao, B.-X., Shi, Z., Abdelsadik, A., Younis, A. E., Abbasi, I. N., Sundus, J., Hussein, A. B., Geng, Y., & others. (2025). Hif-1α ablation reduces the efficiency of NeuroD1 gene-based therapy and aggravates the brain damage following ischemic stroke. Expert Opinion on Drug Delivery.

2. Fang, Z., Shen, G., Lou, C., Botchway, B. O. A., Lu, Q., Yang, Q., & Amin, N. (2024). Neuroprotective effect of triptolide on neuronal inflammation in rats with mild brain injury. IBRO Neuroscience Reports.

3. Wang, Y., Fang, M., Ren, Q., Qi, W., Bai, X., Amin, N., Zhang, X., Li, Z., & Zhang, L. (2024). Sox17 protects human brain microvascular endothelial cells from AngII-induced injury by regulating autophagy and apoptosis. Molecular and Cellular Biochemistry.

4. Amin, N., Abbasi, I. N., Wu, F., Shi, Z., Sundus, J., Badry, A., Yuan, X., Zhao, B.-X., Pan, J., Mi, X.-D., & others. (2024). The Janus face of HIF-1α in ischemic stroke and the possible associated pathways. Neurochemistry International.

5. Zhao, B., Zhang, S., Amin, N., Pan, J., Wu, F., Shen, G., Tan, M., Shi, Z., & Geng, Y. (2024). Thymoquinone regulates microglial M1/M2 polarization after cerebral ischemia-reperfusion injury via the TLR4 signaling pathway. NeuroToxicology.